Medtronic (MDT) reached $78.23 at the closing of the latest trading day, reflecting a -3.34% change

On June 30, 2026, Medtronic PLC (MDT) shares fell 3.3% today, bringing the current price to $78.23.

Globus Medical or Medtronic? See why Globus Medical's stronger growth, innovation and analyst upside

Investors turn to dividend-yielding stocks in turbulent markets. Benzinga offers latest analyst rati

The Nasdaq 100 has tripled since 2020, but 10 mega-caps still trade below pre-Covid levels. Who'

During market turbulence, investors turn to dividend-yielding stocks. Benzinga offers latest analyst

Goldman Sachs analyst David Roman maintains Medtronic (NYSE:MDT) with a Neutral and lowers the pr

Bernstein analyst Lee Hambright maintains Medtronic (NYSE:MDT) with a Outperform and lowers the p

BTIG upgrades Medtronic (MDT) to Buy with a $90 target after a strong Q4 revenue beat and accelerati

UBS analyst Priya Sachdeva maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price tar

RBC Capital analyst Shagun Singh reiterates Medtronic (NYSE:MDT) with a Outperform and maintains

Wells Fargo analyst Larry Biegelsen maintains Medtronic (NYSE:MDT) with a Overweight and lowers t

Leerink Partners analyst Mike Kratky maintains Medtronic (NYSE:MDT) with a Outperform and lowers

Baird analyst David Rescott maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price ta

Mizuho analyst Anthony Petrone maintains Medtronic (NYSE:MDT) with a Outperform and lowers the pr

Needham analyst Mike Matson maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target

Medtronic (MDT) stock jumps after beating Q4 revenue expectations, driven by strong growth in cardio

Medtronic (NYSE:MDT) reported quarterly earnings of $1.55 per share which beat the analyst consensus

General surgery indication including hernia repair — 510(k) clearance submittedEmbrace Gynecology In

ICE catheters provide real-time, high-resolution imaging of the heart during electrophysiology (EP)

Medtronic (NYSE:MDT) reported quarterly earnings of $1.50 per share which missed the analyst consens

June 3, 2026: Polymarket traders tilt bearish on the S&P 500 despite record highs, AI optimism a

Medtronic (MDT) to report Q4 2026 results on 6/3, expected revenue of $9.61B & EPS of $1.55. Rec

U.S. stocks closed higher on Tues. Dow Jones up 0.45%. CNN Fear & Greed index shows positive mar

The S&P 500 Index is at crossroads as it sits at a record high. Here are the top three catalysts

Major M&A deals this week include Cohere acquiring Reliant AI and Authentic Brands buys denim br

The acquisition continues Medtronic's momentum in driving strategic deals that further build out

Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO) ("Orchestra BioMed" or the "Company"),

Jim Cramer says investors are aggressively favoring AI stocks while heavily punishing companies that

Payment fulfills previously disclosed funding commitment of $20 million and supports planned complet

The health care sector has oversold stocks with RSI below 30, presenting an opportunity for traders

Together, the two BDDs for AVIM Therapy cover indications that encompass both the broader population

Investors turn to dividend-yielding stocks during market turbulence. Benzinga's database offers

HRS late-breaking data: Interim results highlight six-month outcomes for patients treated with the S

UBS analyst Priya Sachdeva maintains Medtronic (NYSE:MDT) with a Neutral and lowers the price tar

Truist Securities analyst Richard Newitter maintains Medtronic (NYSE:MDT) with a Hold and lowers

Investors turn to high-yielding dividend stocks in turbulent markets. Benzinga readers can check ana

Mizuho analyst Anthony Petrone maintains Medtronic (NYSE:MDT) with a Outperform and lowers the pr

Evercore ISI Group analyst Vijay Kumar maintains Medtronic (NYSE:MDT) with a Outperform and lower

Citigroup analyst Joanne Wuensch maintains Medtronic (NYSE:MDT) with a Buy and lowers the price t

Evercore ISI Group analyst Vijay Kumar maintains Medtronic (NYSE:MDT) with a Outperform and lower

Argus Research analyst David Toung maintains Medtronic (NYSE:MDT) with a Buy and lowers the price

Barclays analyst Matt Miksic maintains Medtronic (NYSE:MDT) with a Overweight and raises the pric

Piper Sandler analyst Matt O'Brien maintains Medtronic (NYSE:MDT) with a Neutral and lowers t

Tempus AI says ALERT trial shows higher valve procedures and faster care, while analysts keep a Buy

MiniMed shows improved pipeline and valuation upside as insulin pump adoption grows despite rising c

ALERT is the largest known multicenter, cluster-randomized trial to date evaluating an automated EHR

GlucoTrack targets a Q2 2026 FDA IDE filing for CGM, backed by clinical data, manufacturing strategy

Built for high reliability, world's only lumenless defibrillation lead approved for placement in